Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection.

Research paper from Europe PMC. Evidence status: source reported.

Published

2022-05-30

Source reference

MED:37118449

DOI

10.1038/s43587-022-00224-w

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

Tut G, Lancaster T, Butler MS, Sylla P, Spalkova E, Bone D, Kaur N, Bentley C, Amin U, Jadir AT, Hulme S, Ayodel M, Dowell AC, Pearce H, Zuo J, Margielewska-Davies S, Verma K, Nicol S, Begum J, Jinks E, Tut E, Bruton R, Krutikov M, Shrotri M, Giddings R, Azmi B, Fuller C, Irwin-Singer A, Hayward A, Copas A, Shallcross L, Moss P. · Nat Aging · research support, non-u.s. gov't; research-article; journal article · Found via: ClinicalTrials.gov result publication

Source: https://europepmc.org/article/MED/37118449. Captured 2026-10-29.

Limitations: Listed by a ClinicalTrials.gov registration as a result publication of that study, and fetched by its PubMed ID. The registry's listing is the sponsor's statement; it does not confirm which data the paper used. Preprints may not be peer reviewed.